New generic chewable tablets are available for osteoarthritis in dogs

A new generic therapy for managing pain and inflammation associated with osteoarthritis and for postoperative pain associated with soft tissue and orthopedic surgeries in dogs has been launched by Irish veterinary pharmaceutical manufacturer Felixvet. The new Carprofen Soft Chewable Tablets are therapeutically equivalent to Rimadyl (Zoetis) with the same safety and efficacy, according to Felixvet, which has its’ North American headquarters in Kansas City, Missouri.^1,2

Photo: Ines Hasenau/Adobe Stock

A nonsteroidal anti-inflammatory, Carprofen Soft Chewable Tablets are available in 3 strengths: 25 mg, 75 mg and 100 mg. Each tablet is scored for easy and accurate dosing, according to Felixvet. Additionally, these tablets are beef flavored to allow a palatable oral administration.¹

Carprofen Soft Chewable Tablets is the latest addition to Felixvet’s portfolio of carprofen products. The company currently offers veterinarians 5 different forms of carprofen, of which each are specifically designed to meet diverse customer needs.¹

“We are excited to announce the launch of our fifth carprofen product offering in the US market," Vince Palasota, president of North America at Felixvet, said in a news release.¹ “This development marks a significant step forward in providing quality, affordable health care solutions for pets without sacrificing efficacy, safety or reliability.”

OA is the No. 1 cause of chronic pain in dogs and can have a large impact on both patient and owner quality of life. In a lecture at the 2025 Fetch dvm360 Conference in Charlotte, North Carolina, presenter David Dycus, DVM, MS, CCRP, DACVS-SA, founder and orthopedic surgeon at Fusion Veterinary Orthopedics in Lanham, Maryland, told veterinarians that, because it is an inflammatory disease that occurs secondary to other disease processes, it can occur in dogs of any age.³

Dycus noted that multimodal management is essential for patients with OA. He included weight management, daily activity, environmental changes, omega-3 supplementation and polysulfated glycosaminoglycan (Adequan Canine; American Regent Animal Health) therapy for joint support as disease management options.“Our primary focus in patients with OA should be on modulating, mitigating, and/or eliminating inflammation,” he said.³

References

1. Felixvet launches carprofen soft chewable tablets. News release. Felixvet. April 3, 2025.
2. Carprofen Soft Chewable Tablets. Felixvet. Accessed April 4, 2025. https://www.felixvet.com/product/carprofen-soft-chewable-tablets/#
3. Boatright K. Make a patient specific plan for canine osteoarthritis. dvm360. March 24, 2025. Accessed April 4, 2025. https://www.dvm360.com/view/make-a-patient-specific-plan-for-canine-osteoarthritis